Anzeige
Mehr »
Samstag, 11.04.2026 - Börsentäglich über 12.000 News
Die Bohrer rollen - der Durchbruch-Moment ist da
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Tradegate
08.04.26 | 17:26
3,720 Euro
-8,37 % -0,340
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,0004,04010.04.
3,9604,16010.04.

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiLifecore Biomedical, Inc.: Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit1
26.03.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)1
26.03.Lifecore Biomedical Inks Two New Agreements with Existing US Customer2
26.03.Lifecore signs two manufacturing deals with existing customer2
26.03.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer244-- Site Transfer Agreement for the Manufacture of Commercially Marketed Product -- -- Second Agreement Supports the Expansion of Product Commercially Manufactured at Lifecore to a New Delivery System...
► Artikel lesen
23.03.Lifecore Biomedical signs third site transfer deal in five months1
23.03.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company122-- Agreement for the Commercial Manufacture of Established, Approved Aesthetic Product -- -- Third Commercial Site Transfer Agreement Win in Five Months -- -- Program Expected to Generate Commercial...
► Artikel lesen
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
17.03.Lifecore Biomedical stellt strategische Neuausrichtung und Wachstumsziele vor4
17.03.Lifecore Stock Sinks As Delayed Launches Push Growth Further Out3
16.03.Lifecore targets 12% revenue CAGR through 2029 as midterm pipeline milestones shift3
16.03.Lifecore Biomedical: EPS verfehlt Schätzungen - Umsatz schlechter als erwartet4
16.03.Lifecore Biomedical GAAP EPS of -$0.16, revenue of $35.75M5
16.03.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
10.03.Lifecore Biomedical, Inc.: Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum1
09.03.Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 20261
05.03.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
04.03.Lifecore to manufacture acne treatment batches for Indomo1
04.03.Lifecore übernimmt Herstellung von Akne-Wirkstoff für Indomo2
04.03.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment569Indomo Developing Fast-Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen, its Proprietary Intradermal Self-Injection Device Lifecore to Manufacture Drug...
► Artikel lesen
17.02.Lifecore Biomedical, Inc.: Lifecore Biomedical to Participate at DCAT Week 20262
Weiter >>
50 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1